Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1147621]Researchers: Dr Michael Griffin (Principal investigator) , Dr Tracy Putoczki
Brief description Interleukin (IL)-11 is a soluble signalling molecule that is associated with many types of cancer. We have recently discovered that IL-11 signalling is a novel and tractable therapeutic target for the treatment of colon cancer. The aims of this proposal are to understand the structural details of IL-11 signalling. We will use this information to develop new and improved therapeutics for colon cancer.
Funding Amount $AUD 625,830.15
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1147621
- PURL : https://purl.org/au-research/grants/nhmrc/1147621
